Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Here's the Latest Marijuana Stock to Aim for the U.S. Market

By Dan Caplinger - Updated Apr 15, 2019 at 5:00PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors may soon have another choice for betting on cannabis.

Demand in the new year for marijuana stocks has been strong, as investors seek to rebound from their losses in 2018. That has many cannabis companies looking to make their shares more readily available to investors in the U.S. market.

Last year, several up-and-coming players in the cannabis space listed their shares on U.S. stock exchanges, either through dual listings in addition to their already-public shares on Canadian exchanges or by going straight to an initial public offering in the U.S. Today, Canadian cannabis producer CannTrust Holdings ( CNTTQ 0.00% ) became the latest marijuana stock to seek a place on the New York Stock Exchange. By doing so, the company hopes to draw more attention in an increasingly crowded space for marijuana-related businesses.

Hand holding one cannabis leaf in front of a large patch of cannabis plants.

Image source: Getty Images.

What CannTrust said

In a press release, CannTrust simply stated that it has applied to list its common shares on the New York Stock Exchange. The listing request is subject to approval of the exchange, and CannTrust will have to meet all the listing requirements in order to have its shares offered there. Among those requirements is filing a registration statement with the U.S. Securities and Exchange Commission, which the company has done. Although CannTrust didn't predict when it will first trade on the NYSE, it committed to doing so once it's gotten all the approvals it needs to move forward.

CannTrust sees the value of a NYSE listing both for its reputation and for access to capital. In CEO Peter Aceto's words, "CannTrust has firmly established itself as one of the top licensed producers in Canada, with a global platform rooted in trust, science, and innovation. A listing on the NYSE is a natural step forward in our evolution as we look to broaden our investor base, increase the Company's exposure, and expand our business on an international scale."

Late to the game?

Some detractors will argue that CannTrust took longer than it needed to before making this move. After all, several other companies were quicker to get themselves listed on U.S. exchanges:

Company

Market Cap

First Trade Date on NYSE/Nasdaq

CannTrust

$573 million

TBD

Aurora Cannabis ( ACB 2.23% )

$5.24 billion

October 2018

Aphria ( APHA )

$1.60 billion

November 2018

Cronos Group ( CRON 3.97% )

$2.22 billion

February 2018

Canopy Growth ( CGC 1.50% )

$9.84 billion

May 2018

Tilray ( TLRY )

$6.7 billion

July 2018

Data source: Yahoo! Finance. Uses $1 = CA$1.3311 exchange rate.

Admittedly, those rivals all have much larger market capitalizations than CannTrust does. Yet from a revenue perspective, CannTrust is well ahead of Cronos and has top-line figures approaching those of Tilray and Aphria.

Others might criticize CannTrust for bad timing, since its stock is down more than 30% over the past year as measured by its Canada-listed shares. Yet those declines are consistent with what several other players in the space have suffered, and a solid gain so far in 2019 points to the potential for a longer-term rebound.

The benefits of the NYSE

One thing that CannTrust hopes to achieve from the listing is more visibility and trading liquidity. Currently, CannTrust's over-the-counter shares in the U.S. have seen average daily volume of around 370,000 shares, or less than $2 million. That's far less than the 3 million to 14 million share trading volume that previously listed stocks enjoy -- and with much higher share prices, some of those stocks see volume of several hundred million dollars each and every day.

CannTrust has several growth opportunities it wants investors to see. Moves like the opening of its expanded Niagara greenhouse facility, new brands of recreational cannabis products, and the naming of Aceto as CEO have set the stage for a promising future for the business. Now, the company is looking to push forward, and a NYSE listing could be the catalyst to a host of further strategic moves.

Pick your marijuana stocks well

It used to be that investors in cannabis had to settle for the few stocks they could get their hands on. But as more companies like CannTrust become more easily available to U.S. investors, you can afford to be more discriminating. By focusing on the best marijuana stocks in the market, you'll have the best chance to take full advantage of the profit opportunities available in the cannabis industry right now.

Check out the latest CannTrust Holdings earnings call transcript.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

CannTrust Holdings Inc. Stock Quote
CannTrust Holdings Inc.
CNTTQ
$0.01 (0.00%) $0.00
CannTrust Holdings Inc. Stock Quote
CannTrust Holdings Inc.
TRST
Aurora Cannabis Stock Quote
Aurora Cannabis
ACB
$5.95 (2.23%) $0.13
Canopy Growth Stock Quote
Canopy Growth
CGC
$10.14 (1.50%) $0.15
Cronos Group Stock Quote
Cronos Group
CRON
$4.33 (3.97%) $0.17
Tilray Stock Quote
Tilray
TLRY
Aphria Stock Quote
Aphria
APHA

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
624%
 
S&P 500 Returns
140%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/06/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.